Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 6153 - 6160 of 11540 results
OTC Drug Manufacturers: Keep Your Eyes and Ears on Congress
October 10, 2017| Blog| Viewpoint
Building a Health App? Part 4: Avoiding an FTC Enforcement Action
October 10, 2017| Blog| Viewpoint
Department of Veterans Affairs Aims to Trump State Telemedicine Rules
October 10, 2017| Blog| Viewpoint
Health Care Weekly Preview from ML Strategies – Week of October 9, 2017
October 10, 2017| Blog| Viewpoint
General Plastic Industrial Co. v. Canon Kabushiki Kaisha: PTAB Explains Factors for Follow-On Petitions
October 9, 2017| Blog| Viewpoint
InsureTech Connect 2017 Panel Discussion: Maximizing Profits via Products and Alternative Business Model Innovation
October 9, 2017| Article| Viewpoint
Federal Trade Commission Announces Workshop on Competition in the Prescription Drug Market
October 9, 2017| Blog| Viewpoint
Canada Institutes Certificates of Supplementary Protection for Approved Drug Products
October 6, 2017| Blog| Viewpoint
News & Press Releases
Mintz Announces Partnership with Lineal’s Amplify Technology Suite
November 19, 2024
Mintz has partnered with Lineal, a leader in legal technology and data review solutions to assist with client services delivery. The collaboration brings Lineal’s Amplify Suite—an advanced RelativityOne integration—into Mintz’s practice to enhance early data assessment (EDA), streamline modern data review, and manage strategic decision calls.
Mintz Advises Aspen Aerogels on $98M Follow-on Offering
November 19, 2024
Mintz advised Aspen Aerogels, Inc. (NYSE: ASPN), a technology leader in sustainability and electrification solutions, on a registered follow-on offering of 4,887,500 shares of its common stock, which included 637,500 shares pursuant to the underwriters’ option to purchase additional shares of its common stock. The price to the public in the offering was $20.00 per share and the gross proceeds to Aspen from the offering were approximately $98 million, before deducting underwriting discounts and commissions and estimated offering expenses.
Mintz Advises Charlesbank Capital Partners on Strategic Investment with IMPLAN Group
November 18, 2024
Mintz advised Charlesbank Capital Partners (“Charlesbank”), a middle-market private equity firm with more than $22 billion in total assets, on a strategic investment with IMPLAN Group LLC (“IMPLAN”), a leading provider of economic impact data and analytical software.
Events
BIPLA International & Medical Devices Event: Global Strategic Considerations for Medical Device Portfolios
Boston, Massachusetts
Podcasts
Health Law Diagnosed – Women Leaders in Health Care: Investing in Women’s Health
October 11, 2024| Podcast|
Health Law Diagnosed – Women Leaders in Health Care: The Emerging Role of AI in Health Care
March 22, 2024| Podcast|